CDS

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• arthralgia, aromatase inhibitor-induced [Insufficient Evidence]
• cancer [Insufficient Evidence]
• cataracts [Possibly Effective]
• colorectal adenoma [Insufficient Evidence]
• dry eye disease [Insufficient Evidence]
• exercise-induced muscle soreness [Insufficient Evidence]
• gastritis [Insufficient Evidence]
• GERD [Insufficient Evidence]
• hyperlipidemia [Insufficient Evidence]
• interstitial cystitis [Insufficient Evidence]
• Kashin-Beck disease [Insufficient Evidence]
• knee pain [Insufficient Evidence]
• osteoarthritis [Possibly Effective]
• osteoporosis [Insufficient Evidence]
• overall mortality [Insufficient Evidence]
• psoriasis [Insufficient Evidence]
• skin aging [Insufficient Evidence]
• stroke prevention [Insufficient Evidence]
• temporomandibular disorder [Insufficient Evidence]
• urinary incontinence [Insufficient Evidence]
• UTI [Insufficient Evidence]